Page 1

221 VERTEX THE SCIENCE of POSSIBILITY VX - 147 PHASE 2 RESULTS SUPPORT ADVANCEMENT TO PIVOTAL DEVELOPMENT IN A BROAD POPULATION OF PEOPLE WITH APOL1 MEDIATED KIDNEY DISEASE DECEMBER 1 , 2021 Ⓒ2021 Vertex Pharmaceuticals Incorporated